Naoki Sugano

1.3k total citations
41 papers, 1.1k citations indexed

About

Naoki Sugano is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Naoki Sugano has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 15 papers in Molecular Biology and 15 papers in Nephrology. Recurrent topics in Naoki Sugano's work include Blood Pressure and Hypertension Studies (9 papers), Hormonal Regulation and Hypertension (9 papers) and Gout, Hyperuricemia, Uric Acid (7 papers). Naoki Sugano is often cited by papers focused on Blood Pressure and Hypertension Studies (9 papers), Hormonal Regulation and Hypertension (9 papers) and Gout, Hyperuricemia, Uric Acid (7 papers). Naoki Sugano collaborates with scholars based in Japan, United States and Norway. Naoki Sugano's co-authors include Kôichi Hayashi, Shu Wakino, Koichiro Homma, Takao Saruta, Satoru Tatematsu, Kyoko Yoshioka, Kazuhiro Hasegawa, Takeshi Kanda, Yuri Ozawa and Takashi Yokoo and has published in prestigious journals such as PLoS ONE, Circulation Research and The FASEB Journal.

In The Last Decade

Naoki Sugano

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Sugano Japan 15 412 347 250 244 176 41 1.1k
Nada Cordasic Germany 21 306 0.7× 299 0.9× 184 0.7× 163 0.7× 181 1.0× 48 1.0k
Shirong Zheng United States 20 387 0.9× 649 1.9× 314 1.3× 299 1.2× 129 0.7× 35 1.5k
Satoru Tatematsu Japan 17 351 0.9× 522 1.5× 166 0.7× 447 1.8× 176 1.0× 29 1.3k
Hiroe Toba Japan 22 490 1.2× 486 1.4× 97 0.4× 159 0.7× 226 1.3× 52 1.3k
Malou Friederich‐Persson Sweden 15 165 0.4× 229 0.7× 158 0.6× 232 1.0× 169 1.0× 25 828
Zaiming Luo United States 18 410 1.0× 341 1.0× 145 0.6× 507 2.1× 133 0.8× 27 1.2k
Mizuo Mifune Japan 20 334 0.8× 518 1.5× 219 0.9× 152 0.6× 338 1.9× 36 1.2k
Francisco J. Fenoy Spain 22 461 1.1× 303 0.9× 299 1.2× 376 1.5× 232 1.3× 45 1.3k
Wei‐Zhong Ying United States 22 270 0.7× 522 1.5× 331 1.3× 192 0.8× 169 1.0× 45 1.2k
Shawna A. Cooper United States 16 385 0.9× 432 1.2× 122 0.5× 263 1.1× 346 2.0× 22 1.3k

Countries citing papers authored by Naoki Sugano

Since Specialization
Citations

This map shows the geographic impact of Naoki Sugano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Sugano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Sugano more than expected).

Fields of papers citing papers by Naoki Sugano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Sugano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Sugano. The network helps show where Naoki Sugano may publish in the future.

Co-authorship network of co-authors of Naoki Sugano

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Sugano. A scholar is included among the top collaborators of Naoki Sugano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Sugano. Naoki Sugano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujiwara, Akira, Naoki Sugano, Kaori Hayashi, et al.. (2025). Evaluating blood pressure targets in chronic kidney disease: a systematic review and meta-analysis. Hypertension Research. 48(9). 2358–2367. 1 indexed citations
2.
Kobayashi, Akimitsu, Izumi Yamamoto, Naoki Sugano, et al.. (2023). A Case of Hypokalemia Caused by Left Native Renal Artery Stenosis in a Kidney Transplant Recipient. ˜The œNephron journals/Nephron journals. 147(Suppl. 1). 46–52. 1 indexed citations
3.
Sugano, Naoki, et al.. (2020). New Concept of Onco-Hypertension and Future Perspectives. Hypertension. 77(1). 16–27. 47 indexed citations
4.
Sugano, Naoki, Yukio Maruyama, Iwao Ohno, et al.. (2019). Effect of hyperuricemia and treatment for hyperuricemia in Japanese hemodialysis patients: A cohort study. PLoS ONE. 14(6). e0217859–e0217859. 10 indexed citations
5.
Sugano, Naoki, et al.. (2019). Azilsartan causes natriuresis due to its sympatholytic action in kidney disease. Hypertension Research. 42(10). 1507–1517. 7 indexed citations
6.
Miyazaki, Yoichi, Taiji Matsusaka, Naoki Sugano, et al.. (2017). Forced expression of vascular endothelial growth factor-A in podocytes decreases mesangial cell numbers and attenuates endothelial cell differentiation in the mouse glomerulus. Clinical and Experimental Nephrology. 22(2). 266–274. 11 indexed citations
7.
Kuriyama, Satoru, Yukio Maruyama, Shinichiro Nishio, et al.. (2015). Serum uric acid and the incidence of CKD and hypertension. Clinical and Experimental Nephrology. 19(6). 1127–1134. 36 indexed citations
8.
Sugano, Naoki, Kôichi Hayashi, Tatsuo Hosoya, & Takashi Yokoo. (2014). Mechanistic View of Renal Protective Action of Calcium Channel Blockade. Current Hypertension Reviews. 9(3). 187–192. 7 indexed citations
9.
Sugano, Naoki, Keitaro Yokoyama, Yoichiro Hara, et al.. (2014). Monitoring of body water composition by the simultaneous use of bioelectrical impedance analysis and Crit-Line® during hemodialysis. Clinical and Experimental Nephrology. 18(6). 944–951. 1 indexed citations
10.
Hayashi, Kôichi, Koichiro Homma, Shu Wakino, et al.. (2010). T-Type Ca Channel Blockade as a Determinant of Kidney Protection. The Keio Journal of Medicine. 59(3). 84–95. 40 indexed citations
11.
Kobayashi, Hideyuki, Goro Tokudome, Naoki Sugano, et al.. (2009). Insulin resistance is a risk factor for the progression of chronic kidney disease. Clinical Nephrology. 71(6). 643–651. 47 indexed citations
12.
Yoshioka, Kyoko, Shu Wakino, Koichiro Homma, et al.. (2008). Renal Cytochrome P450 as a Determinant of Impaired Natriuresis by PPAR‐γ Ligands in Ovariectomized Obese Rats. Obesity. 16(5). 965–971. 8 indexed citations
13.
Sugano, Naoki, Shu Wakino, Takeshi Kanda, et al.. (2008). T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Kidney International. 73(7). 826–834. 40 indexed citations
14.
Hasegawa, Kazuhiro, Shu Wakino, Satoru Tatematsu, et al.. (2007). Role of Asymmetric Dimethylarginine in Vascular Injury in Transgenic Mice Overexpressing Dimethylarginie Dimethylaminohydrolase 2. Circulation Research. 101(2). e2–10. 105 indexed citations
15.
Tatematsu, Satoru, Shu Wakino, Takeshi Kanda, et al.. (2007). Role of Nitric Oxide–Producing and–Degrading Pathways in Coronary Endothelial Dysfunction in Chronic Kidney Disease. Journal of the American Society of Nephrology. 18(3). 741–749. 58 indexed citations
16.
Hayashi, Kôichi, Shu Wakino, Naoki Sugano, et al.. (2007). Ca2+Channel Subtypes and Pharmacology in the Kidney. Circulation Research. 100(3). 342–353. 172 indexed citations
17.
Hayashi, Kôichi, Shu Wakino, Takeshi Kanda, et al.. (2006). Molecular Mechanisms and Therapeutic Strategies of Chronic Renal Injury: Role of Rho-Kinase in the Development of Renal Injury. Journal of Pharmacological Sciences. 100(1). 29–33. 27 indexed citations
18.
Hayashi, Kôichi, Shu Wakino, Koichiro Homma, Naoki Sugano, & Takao Saruta. (2005). Pathophysiological Significance of T-type Ca2+ Channels: Role of T-type Ca2+ Channels in Renal Microcirculation. Journal of Pharmacological Sciences. 99(3). 221–227. 37 indexed citations
19.
Hasegawa, Kazuhiro, Shu Wakino, Takeshi Kanda, et al.. (2005). Divergent Action of Calcium Channel Blockers on ATP-Binding Cassette Protein Expression. Journal of Cardiovascular Pharmacology. 46(6). 787–793. 8 indexed citations
20.
Wakino, Shu, Kôichi Hayashi, Satoru Tatematsu, et al.. (2005). Pioglitazone Lowers Systemic Asymmetric Dimethylarginine by Inducing Dimethylarginine Dimethylaminohydrolase in Rats. Hypertension Research. 28(3). 255–262. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nada Cordasic Breakdown of academic impact, for papers by Shirong Zheng Breakdown of academic impact, for papers by Satoru Tatematsu Breakdown of academic impact, for papers by Hiroe Toba Breakdown of academic impact, for papers by Malou Friederich‐Persson Breakdown of academic impact, for papers by Zaiming Luo Breakdown of academic impact, for papers by Mizuo Mifune Breakdown of academic impact, for papers by Francisco J. Fenoy Breakdown of academic impact, for papers by Wei‐Zhong Ying Breakdown of academic impact, for papers by Shawna A. Cooper
Rankless by CCL
2026